Fresenius | FRE - Current Assets

Stock Price
52.06
Daily Change
-0.02 -0.04%
Monthly
7.41%
Yearly
42.47%
Q1 Forecast
50.68

Fresenius reported EUR12.06B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akzo Nobel EUR 6.06B 19M Dec/2025
Alcon AG USD 6.33B 27M Sep/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
BASF EUR 33.09B 1.19B Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Beiersdorf EUR 6.65B 212M Jun/2025
DaVita Healthcare Partners USD 4.06B 53.82M Dec/2025
Demant DKK 10.08B 128M Dec/2025
E.ON EUR 21.8B 1.76B Sep/2025
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.82B 311.36M Sep/2025
Getinge SEK 18.16B 1.83B Dec/2024
Givaudan CHF 4.24B 629M Jun/2024
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GN Store Nord DKK 8.64B 105M Dec/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Philips EUR 9.93B 654M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
RWE EUR 26.49B 3.32B Sep/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025